Milestone for Seattle VA Marrow Transplant Unit

In October 2016, the Marrow Transplant Unit at the Seattle VA performed its 1,500th hematopoietic stem cell transplant since opening in 1982.

Today’s cancer care comprises multiple goals and approaches, including early detection, prevention, and cure.

Recent advancements:

Breast Cancer Initiative 2.5

Breast cancer is the most prevalent cancer in women worldwide. It is estimated that 5.8 million women will die from breast cancer by 2025. A disproportionate number of these deaths will occur in low-resource settings around the world. 

Professor Julie Gralow is co-chairing the global campaign: "Breast Cancer Initiative 2.5 (BCI2.5)"  which aims to reduce disparities in breast cancer outcomes for 2.5 million women by 2025. 

Blood stem cell transplantation for immune deficiencies

Dr. Rainer Storb, professor (Medical Oncology) has received a $12.9 million grant from the National Heart, Lung, and Blood Institute to improve treatments for patients with inborn diseases of the immune system and red blood cells. Storb and collaborators will launch a five-year, bench-to-bedside research program that seeks to refine treatments based on blood stem cell transplantation for immune deficiencies, such as the condition commonly known as “bubble-boy disease”, and non-cancerous disorders of red blood cells, such as sickle-cell disease. Their goal is to make transplantation safer and more widely available to people facing these diseases.

Top Cancer Doctors 

Newsweek presented its list of the top cancer doctors of 2015 in a special issue dedicated to cancer.

From the Department of Medicine:

  • Fred Appelbaum
  • Anthony Back
  • William Bensinger
  • Joachim Deeg
  • Mary (Nora) Disis
  • Georgiana Ellis
  • Elihu Estey
  • Julie Gralow
  • Celestia Higano
  • Michael Linenberger
  • Gary Lyman
  • David Maloney
  • Renato Martins
  • Paul Nghiem
  • Oliver Press
  • F. Marc Stewart
  • John Thompson